Are you referring to me? I assume not, but just checking.
Glad for you.
On the other hand anyone picking up BEAR/ BBOZ and waiting for the market to crash?
Are you referring to me? I assume not, but just checking.
Glad for you.
Sorry? I don't understand.
I wonder if systemic bought into DSH last year.. what a disaster!
Are you referring to me? I assume not, but just checking.
Going back to the OP, I realised that I don't have to look at quality (as I did in a previous comment) - the request is for prospects liked.
Okay, so if I had to pick some stocks that I had to hold for (say) 5 years...I'd stick to value / cheap stuff. I wouldn't worry too much about quality. I wouldn't look at momentum as I normally do. I'd be going for a basket of cheap stuff based purely on the mean reversion of value. This is usually the sort of list of stocks that normal people wouldn't want to own; too scary!
...
DSH Dick Smith Holdings
I think ggkfc is asking because you produced a list containing DSH (and others) back in Dec.
FWIW, the 3 month performance of your list looks like this (last column = percentage change since 14 Dec 2015).
If you put DSH at -100%, you'd still left with an average of +4.2% across the 25 stocks. Obviously 3-month performance is hardly befitting the "long term" thread idea.
I think ggkfc is asking because you produced a list containing DSH (and others) back in Dec.
FWIW, the 3 month performance of your list looks like this (last column = percentage change since 14 Dec 2015).
View attachment 66090
If you put DSH at -100%, you'd still left with an average of +4.2% across the 25 stocks. Obviously 3-month performance is hardly befitting the "long term" thread idea.
haha you are right!
i thought he had bought into DSH!
Adslot (ADJ)
Global digital publishing platform for advertising. Just about to become profitable based on trend of sales. But not anticipated to become profitable ~2017 due to ongoing expansion of the business throughout various countries.
Risks - other than the obvious one of running out of money - being beaten in this space by another competitor;
or if successful, being bought out before the upside is fully realised.
One to take a punt on.
Disclosure - holding via FAC purchase.
(4th-December-2015) At the Micro end of the scale.
i hold
- HZR - Hazer, has blue sky technology commercializing Iron + NG to Graphite & Hydrogen.
- CTT - Food Revolution, Health drinks targeting the Chinese market.
- NRR - Alcidion Corporation, Patient/hospital management software.
One share that I have been buying into with a long term view (more than five years) is TPI enterprises (TPE). It manufacturers/refines narcotics into the concentrates that can be used to produce pain killers. It has a few strong competitive advantages that I like:
The first is the regulatory barriers to entry. It takes substantial time and effort to get through all the red tape to receive a license to manufacture narcotics legally. I believe there is also a limit on how many licenses are given out, or something to that extent - at least the cost of invested capital and the required return to justify the time and money needed to get into the business.
The second is their unique way/technology of refining the narcotics. They use a water based refining process which costs about 20% of the initial required invested capital when compared to the traditional method. Moreover, expanding the facilities and they're production capacity has similarly reduced costs. lower required capital expenditure means less shareholder dilution from the company needing to raise additional cash and also greater return on the invested capital.
in conjunction with their refining process, TPE has also modified the traditional harvester to reduce the amount of chaff that gets collected in the machine. The result is that the raw material brought in has a much higher concentration of raw narcotics, and the production capacity has jumped by about 50% from 100 tonnes to 150 tonnes.
In terms of profitability, they hit break even at 30 tonnes and recently announced a contract worth $30m - or about 14 tonnes. if they hit 100 tonnes in sales by 2019 - they're own stated goals - they will hit $30m in ebitda a year with minimal expenses after that.
I would love to hear what other members thought.
One share that I have been buying into with a long term view (more than five years) is TPI enterprises (TPE). It manufacturers/refines narcotics into the concentrates that can be used to produce pain killers. It has a few strong competitive advantages that I like:
The first is the regulatory barriers to entry. It takes substantial time and effort to get through all the red tape to receive a license to manufacture narcotics legally. I believe there is also a limit on how many licenses are given out, or something to that extent - at least the cost of invested capital and the required return to justify the time and money needed to get into the business.
The second is their unique way/technology of refining the narcotics. They use a water based refining process which costs about 20% of the initial required invested capital when compared to the traditional method. Moreover, expanding the facilities and they're production capacity has similarly reduced costs. lower required capital expenditure means less shareholder dilution from the company needing to raise additional cash and also greater return on the invested capital.
in conjunction with their refining process, TPE has also modified the traditional harvester to reduce the amount of chaff that gets collected in the machine. The result is that the raw material brought in has a much higher concentration of raw narcotics, and the production capacity has jumped by about 50% from 100 tonnes to 150 tonnes.
In terms of profitability, they hit break even at 30 tonnes and recently announced a contract worth $30m - or about 14 tonnes. if they hit 100 tonnes in sales by 2019 - they're own stated goals - they will hit $30m in ebitda a year with minimal expenses after that.
I would love to hear what other members thought.
'Where did you find the information about $30M EBITDA from 100tonnes? '
page 24 of the AGM presentation:
View attachment 67820
''....but I can only see one financial statement at present Dec 15 on Lincoln indictors which shows that the company based on the financials is in a Distressed state presently.'
- My view is that with major shareholders such as Washington H. Soul Pattinson and Thorney group, the chance of such major players letting this business go bankrupt is unlikely. The evidence of this being the July 27 announcement of the extension of the $30m loan facility from WHSP and the recent raising of $4m from the incoming director - simon moore.
I wouldn't pay too much attention to what Lincoln indicators has to say...
One share that I have been buying into with a long term view (more than five years) is TPI enterprises (TPE). It manufacturers/refines narcotics into the concentrates that can be used to produce pain killers. It has a few strong competitive advantages that I like:
The first is the regulatory barriers to entry. It takes substantial time and effort to get through all the red tape to receive a license to manufacture narcotics legally. I believe there is also a limit on how many licenses are given out, or something to that extent - at least the cost of invested capital and the required return to justify the time and money needed to get into the business.
The second is their unique way/technology of refining the narcotics. They use a water based refining process which costs about 20% of the initial required invested capital when compared to the traditional method. Moreover, expanding the facilities and they're production capacity has similarly reduced costs. lower required capital expenditure means less shareholder dilution from the company needing to raise additional cash and also greater return on the invested capital.
in conjunction with their refining process, TPE has also modified the traditional harvester to reduce the amount of chaff that gets collected in the machine. The result is that the raw material brought in has a much higher concentration of raw narcotics, and the production capacity has jumped by about 50% from 100 tonnes to 150 tonnes.
In terms of profitability, they hit break even at 30 tonnes and recently announced a contract worth $30m - or about 14 tonnes. if they hit 100 tonnes in sales by 2019 - they're own stated goals - they will hit $30m in ebitda a year with minimal expenses after that.
I would love to hear what other members thought.
In terms of profitability, they hit break even at 30 tonnes and recently announced a contract worth $30m - or about 14 tonnes. if they hit 100 tonnes in sales by 2019 - they're own stated goals - they will hit $30m in ebitda a year with minimal expenses after that.
Normally I would agree, but a quick scan of the financials shows a VERY distressed company!!
I doubt they are a good long term stock idea - mainly because unless there is a massive change in the fortunes of this business it wont be round in the long term!
... It's more the idea of relying on someone else's analysis without backing it up yourself that I find incorrect.
Im still holding HZR and options, FOD i sold for a small profit and ALC have averaged (double position size) down to now be in a profitable position...picking them is only half the fun.
- HZR, Share price has tripled, up 220% ~ uptrend with some sideways.
- CTT now FOD, Share price down a lot, 25% ~ downtrend.
- NRR now ALC, Share price down a little, 5% ~ down trend that has just turned.
Hello and welcome to Aussie Stock Forums!
To gain full access you must register. Registration is free and takes only a few seconds to complete.
Already a member? Log in here.